Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

4,343 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The non-psychoactive plant cannabinoid, cannabidiol affects cholesterol metabolism-related genes in microglial cells.
Rimmerman N, Juknat A, Kozela E, Levy R, Bradshaw HB, Vogel Z. Rimmerman N, et al. Cell Mol Neurobiol. 2011 Aug;31(6):921-30. doi: 10.1007/s10571-011-9692-3. Epub 2011 Apr 30. Cell Mol Neurobiol. 2011. PMID: 21533611
Differential changes in GPR55 during microglial cell activation.
Pietr M, Kozela E, Levy R, Rimmerman N, Lin YH, Stella N, Vogel Z, Juknat A. Pietr M, et al. FEBS Lett. 2009 Jun 18;583(12):2071-6. doi: 10.1016/j.febslet.2009.05.028. Epub 2009 May 22. FEBS Lett. 2009. PMID: 19464294
Remarkably, these stimuli-induced changes in GPR55 expression are similar to those observed with CB(2)-R, suggesting that both receptors might be involved in neuroinflammation and that their expression is concomitantly controlled by the state of microglial activation....
Remarkably, these stimuli-induced changes in GPR55 expression are similar to those observed with CB(2)-R, suggesting that both recept …
Cannabinoids Delta(9)-tetrahydrocannabinol and cannabidiol differentially inhibit the lipopolysaccharide-activated NF-kappaB and interferon-beta/STAT proinflammatory pathways in BV-2 microglial cells.
Kozela E, Pietr M, Juknat A, Rimmerman N, Levy R, Vogel Z. Kozela E, et al. J Biol Chem. 2010 Jan 15;285(3):1616-26. doi: 10.1074/jbc.M109.069294. Epub 2009 Nov 12. J Biol Chem. 2010. PMID: 19910459 Free PMC article.
Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice.
Kozela E, Lev N, Kaushansky N, Eilam R, Rimmerman N, Levy R, Ben-Nun A, Juknat A, Vogel Z. Kozela E, et al. Br J Pharmacol. 2011 Aug;163(7):1507-19. doi: 10.1111/j.1476-5381.2011.01379.x. Br J Pharmacol. 2011. PMID: 21449980 Free PMC article.
Differential transcriptional profiles mediated by exposure to the cannabinoids cannabidiol and Δ9-tetrahydrocannabinol in BV-2 microglial cells.
Juknat A, Pietr M, Kozela E, Rimmerman N, Levy R, Coppola G, Geschwind D, Vogel Z. Juknat A, et al. Br J Pharmacol. 2012 Apr;165(8):2512-28. doi: 10.1111/j.1476-5381.2011.01461.x. Br J Pharmacol. 2012. PMID: 21542829 Free PMC article.
Microarray and pathway analysis reveal distinct mechanisms underlying cannabinoid-mediated modulation of LPS-induced activation of BV-2 microglial cells.
Juknat A, Pietr M, Kozela E, Rimmerman N, Levy R, Gao F, Coppola G, Geschwind D, Vogel Z. Juknat A, et al. PLoS One. 2013 Apr 24;8(4):e61462. doi: 10.1371/journal.pone.0061462. Print 2013. PLoS One. 2013. PMID: 23637839 Free PMC article.
High-efficiency optogenetic silencing with soma-targeted anion-conducting channelrhodopsins.
Mahn M, Gibor L, Patil P, Cohen-Kashi Malina K, Oring S, Printz Y, Levy R, Lampl I, Yizhar O. Mahn M, et al. Nat Commun. 2018 Oct 8;9(1):4125. doi: 10.1038/s41467-018-06511-8. Nat Commun. 2018. PMID: 30297821 Free PMC article.
Biophysical constraints of optogenetic inhibition at presynaptic terminals.
Mahn M, Prigge M, Ron S, Levy R, Yizhar O. Mahn M, et al. Nat Neurosci. 2016 Apr;19(4):554-6. doi: 10.1038/nn.4266. Epub 2016 Mar 7. Nat Neurosci. 2016. PMID: 26950004 Free PMC article.
4,343 results
Jump to page
Feedback